Differences in Efficacy of Erythropoietin Forms in Animals vs. Humans
Author Information
Author(s): Malonne H
Primary Institution: Laboratoire de Physiologie et de Pharmacologie Fondamentales, Institut de Pharmacie, Université Libre de Bruxelles
Hypothesis
Will differences in efficacy found in animals between recombinant forms of erythropoietin translate into differences in humans?
Conclusion
The study suggests that findings from animal models regarding the efficacy of NESP compared to r-HuEPO may not apply to humans.
Supporting Evidence
- NESP has a longer serum half-life than r-HuEPO in animal models.
- Both NESP and r-HuEPO require increased doses when switching from thrice-weekly to once-weekly regimens.
- Human studies have shown comparable efficacy profiles for NESP and r-HuEPO.
Takeaway
Scientists tested two types of medicine for blood production in animals, but what works in animals might not work the same way in people.
Methodology
The study compared the pharmacokinetics and pharmacodynamics of NESP and r-HuEPO in animal models.
Limitations
The study emphasizes that results from animal models may not be indicative of human responses.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website